| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income/(loss) | -984 | 54,319 | 48,104 | 74,360 |
| Net (gain)/loss on residential whole loans | -32,092 | 5,807 | 42,911 | 90,122 |
| Impairment and other net (gain)/loss on securities and other portfolio investments, net | 38,271 | -15,715 | -17,997 | -27,831 |
| Net (gain)/loss on real estate owned | -3,029 | -2,677 | 232 | -4,442 |
| Accretion of purchase discounts and amortization of purchase premiums on residential whole loans and securities | -3,151 | -1,910 | -505 | 1,187 |
| Provision/(reversal of provision) for credit losses on residential whole loans and other assets | -241 | -276 | 276 | 936 |
| Net (gain)/loss on derivatives used for risk management purposes | 26,767 | 602 | -5,981 | -60,233 |
| Net (gain)/loss on securitized debt measured at fair value through earnings | 22,901 | 1,586 | -21,302 | -22,287 |
| Net margin received/(paid) for derivatives used for risk management purposes | -13,485 | -108 | 724 | 95,452 |
| Net other non-cash (gains)/losses included in net income | 7,253 | 7,711 | 17,003 | 42,685 |
| (increase)/decrease in other assets | -23,612 | 4,699 | 20,839 | -30,003 |
| Increase/(decrease) in other liabilities | 1,070 | -414 | 4,257 | 3,540 |
| Net cash provided by/(used in) operating activities | 71,070 | 37,626 | 14,725 | 23,894 |
| Purchases and origination of residential whole loans, loan related investments and capitalized advances | 675,729 | 658,331 | 678,689 | 1,351,673 |
| Proceeds from sales of residential whole loans | 85,791 | 54,628 | 83,261 | 137,032 |
| Principal payments on residential whole loans and loan related investments | 551,547 | 591,146 | 615,766 | 1,230,027 |
| Purchases of securities | 350,944 | 1,345,070 | 355,811 | 461,825 |
| Proceeds from sales of securities and other assets | 1,561 | 26,023 | 18,173 | 2,617 |
| Principal payments on securities | 128,077 | 117,731 | 43,325 | 128,593 |
| Proceeds from sales of real estate owned | 26,287 | 22,472 | 27,317 | 46,640 |
| Other investing activities | -7,796 | 40,074 | 25,316 | 13,463 |
| Net cash provided by/(used in) investing activities | -225,614 | -1,231,475 | -271,974 | -282,052 |
| Principal payments on financing agreements with mark-to-market collateral provisions | 797,391 | 680,790 | 915,304 | 1,099,127 |
| Proceeds from borrowings under financing agreements with mark-to-market collateral provisions | 1,057,410 | 1,865,247 | 882,908 | 1,594,942 |
| Principal payments on other collateralized financing agreements | 813,830 | 608,191 | 411,992 | 881,267 |
| Proceeds from borrowings under other collateralized financing agreements | 797,120 | 519,624 | 755,468 | 705,835 |
| Payments made for other collateralized financing agreement related costs | 2,953 | 2,853 | 3,920 | 4,119 |
| Redemption and repurchase of convertible senior notes | NaN | 0 | 0 | 0 |
| Proceeds from issuance of senior notes | NaN | 0 | 0 | 0 |
| Payments made for settlements and unwinds of swaps | 6,759 | 1,258 | 8,846 | 17,174 |
| Proceeds from issuance of preferred stock, net of expenses | 3,427 | 4,779 | 4,532 | NaN |
| Payments made for costs related to preferred stock issuance | NaN | NaN | 74 | NaN |
| Proceeds from issuances of common stock, net of expenses | -10 | -7 | -21 | -40 |
| Payments made for the repurchase of common stock | 9,033 | 5,047 | 5,077 | 5,189 |
| Dividends paid on preferred stock | 10,424 | 10,704 | 10,834 | 18,779 |
| Dividends paid on common stock and dividend equivalents | 38,870 | 37,326 | 37,577 | 73,281 |
| Net cash provided by/(used in) financing activities | 178,687 | 1,043,548 | 249,263 | 201,801 |
| Net increase/(decrease) in cash, cash equivalents and restricted cash | 24,143 | -150,301 | -7,986 | -56,357 |
| Cash, cash equivalents and restricted cash at beginning of period | 386,668 | 536,969 | 601,312 | NaN |
| Cash, cash equivalents and restricted cash at end of period | 410,811 | 386,668 | 536,969 | NaN |
MFA FINANCIAL, INC. (MFA)
MFA FINANCIAL, INC. (MFA)